A

Altrartis Therapeutics

Other

Legal name: Altrartis Therapeutics Inc. · Corporation

New York, NY
Explore comparable companies and investor patterns →My company watchlist
$11.0M
Total Raised
1
Form D filings
Aug 2026
First Raise
Oct 2026
Last Raise

From SEC Form D filings. Amounts are totals sold as reported by the company, in USD.

Funding Timeline

Reg D offeringAug 12, 2026
$11.0M raisedOffering size: $11.0M11 investors
Securities: equity
SEC filing File 021-602187

People

Executive officers, directors and promoters named on the company's SEC Form D filings.

F
Florian Brand

Director · Executive Officer · Promoter

Listed Oct 2026Form D
L
Lars Christian Wilde

Director

Listed Oct 2026Form D

Sources

  • SEC Form D
  • SEC CIK2157050